LeadIQ logo
Learn more at LeadIQ.com

Insights

Targeted autoimmune therapies Abata Therapeutics specializes in developing engineered Treg cell therapies for autoimmune diseases such as progressive MS, Type 1 Diabetes, and inclusion body myositis. These tissue-specific treatments offer a unique selling proposition in the market for personalized and effective autoimmune therapies.

Expert leadership team With industry experts in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers, the leadership team at Abata Therapeutics brings a wealth of knowledge and experience. Highlighting the expertise of the leadership can be a compelling sales angle to showcase credibility and competence.

Strategic market positioning Abata Therapeutics' differentiation lies in its focus on transformative Treg therapies for severe autoimmune and inflammatory diseases. Positioning the company as a pioneer in this niche market segment can attract interest from potential partners, investors, and customers seeking innovative solutions.

Recent key hires The recent appointments of key executives such as Joanne Beck as chief technical officer and Leonard

Similar companies to Abata Therapeutics

Abata Therapeutics Tech Stack

Abata Therapeutics uses 8 technology products and services including QuickBooks, Hotjar, cdnjs, and more. Explore Abata Therapeutics's tech stack below.

  • QuickBooks
    Accounting And Finance
  • Hotjar
    Analytics
  • cdnjs
    Content Delivery Network
  • MySQL
    Database
  • Typekit
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery Migrate
    Javascript Libraries
  • WP Engine
    Platform As A Service

Media & News

Abata Therapeutics's Email Address Formats

Abata Therapeutics uses at least 1 format(s):
Abata Therapeutics Email FormatsExamplePercentage
FLast@abatatx.comJDoe@abatatx.com
49%
FMiddleLast@abatatx.comJMichaelDoe@abatatx.com
1%
FLast@abatatx.comJDoe@abatatx.com
49%
FMiddleLast@abatatx.comJMichaelDoe@abatatx.com
1%

Frequently Asked Questions

Where is Abata Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Abata Therapeutics's main headquarters is located at Cambridge, MA US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Abata Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Abata Therapeutics's official website is abatatx.com and has social profiles on LinkedIn.

How much revenue does Abata Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Abata Therapeutics's annual revenue reached $3.8M.

What is Abata Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Abata Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abata Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Abata Therapeutics has approximately 46 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer: A. V. E.Chief Medical Officer: L. D.Chief Scientific Officer: E. C.. Explore Abata Therapeutics's employee directory with LeadIQ.

What industry does Abata Therapeutics belong to?

Minus sign iconPlus sign icon
Abata Therapeutics operates in the Biotechnology Research industry.

What technology does Abata Therapeutics use?

Minus sign iconPlus sign icon
Abata Therapeutics's tech stack includes QuickBooksHotjarcdnjsMySQLTypekitGoogle CloudjQuery MigrateWP Engine.

What is Abata Therapeutics's email format?

Minus sign iconPlus sign icon
Abata Therapeutics's email format typically follows the pattern of . Find more Abata Therapeutics email formats with LeadIQ.

When was Abata Therapeutics founded?

Minus sign iconPlus sign icon
Abata Therapeutics was founded in 2021.
Abata Therapeutics

Abata Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to our lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). We bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers. 

We are bold in our mission and purpose and aim for nothing less than a transformative impact on people’s lives. 

Section iconCompany Overview

Headquarters
Cambridge, MA US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $10M

    Abata Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Abata Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.